European Comission

Olive-Net: Bioactive compounds from Olea europaea: investigation and application in food, cosmetic and pharmaceutical industry.

PI: Alexios Leandros Skaltsounis.
Funding agency: Unión Europea (Research Executive Agency-European Commission)
Funding (in thousands of euros): 1.732.500 €
Duration (funding period): 4 years

Fundación Española de Reumatología

Therapy for the Prevention of HO Recurrence (TPHOR) trial (Stage I).

PI: Rodolfo Gómez Bahamonde
Funding agency: conect4children – Collaborative network for European clinical trials for children (IMI initiative)
Funding (in thousands of euros): 2.500€
Duration (funding period): 2018 to 2019

Instituto de Salud Carlos III

Circulating cell characterization and pharmacological inhibition of abnormal bone growth associated with heterotopic ossification.

IP: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 208.120€
Duration (funding period): 3 years. Started 2020

Integrated biobank unit, 3D biomodels and animal models at IDIS: a complete translational research.

IP: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 232.650 €
Duration (funding period): 3 years. Started 2021

Study of transcription factors associated with changes in DNA methylation during osteoblastogenesis and their role in osteoblast differentiation.

PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 110.715€
Duration (funding period): 3 years. 2017 to 2021.

Role of LCN2 in osteoarthritis-subchondral bone alterations and new pharmacological approaches to block its induction and other innate immune responses in joint tissues.

PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 121.500€
Duration (funding period): 3 years. 2016 to 2018

Fundación Mutua Madrileña

Generation of functional surfaces for externalized endomedullar implants

PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros)): 121.500€
Duration (funding period): 3 years. 2016 to 2018.

Search for soluble factors involved in heterotopic ossification associated with trauma.

PI: Rodolfo Gómez Bahamonde
Funding agency: Fundación Mutua Madrileña
Funding (in thousands of euros): 120.000€
Duration (funding period): 3 years. 2020 to 2023

FECYT

Growth potential groups (GPC). Xunta de Galicia.

PI: Rodolfo Gómez Vaamonde
Agencia financiadora: Xunt de Galicia
Financiación (en miles de euros): 90.000 €.
Duration (financing period): 3 years (2022 – 2024)

Colegio de Médicos de A Coruña

3D models for training in ultrasound-guided puncture techniques.

PI: Ana Lois Iglesias
Funding agency: Colegio de Medicos de Coruña
Funding (in thousands of euros): 1.980€
Duration (funding period): 1 year.

3D printed model for traumatology research and training.

PI: Alberto Jorge Mora
Funding agency: Colegio de Medicos de Coruña
Funding (in thousands of euros): 2.100 €
Duration (funding period): 1 year.

Galician Public Agency for Knowledge Management

New therapy for heterotopic ossification-A4VAL.

PI: Rodolfo Gómez Bahamonde
Funding agency: Agencia pública gallega para la Gestion del Conocimiento (ACIS)
Funding (in thousands of euros): 20.000€
Duration (funding period): 2019

New therapy for heterotopic ossification-I4TRANSF

PI: Rodolfo Gómez Bahamonde
Funding Agency: Galician Public Agency for Knowledge Management (ACIS)
Funding (in thousands of euros): 5.000€
Duration (funding period): 2019

FECYT

STOP ARTHROSIS: blocking the origin of inflammation.

PI: Rodolfo Gómez Bahamonde
Agencia financiadora: Fundación Española para la Ciencia y la tecnología-(FECYT)/ Precipita
Financiación (en miles de euros): 5.730 €.
Duration (financing period): 1 year (2019 – 2020)

AO Trauma Spain

3D printed computerized model for traumatology research and training.

PI: Alberto Jorge Mora
Funding agency: AOTRAUMA Spain
Funding (in thousands of euros): 7.500 CHF
Duration (financing period): 1 year (2019) Year 2019
Proceedings contract/project: SPI 000371
Fundación Española de Reumatología

Search for new drugs to block TLR4-associated inflammation in human arthritis chondrocytes.

PI: Ana Lois Iglesias
Funding agency: Spanish Foundation of Rheumatology (SER)
Funding (in thousands of euros): 22.000 €
Duration (funding period): 2019 to 2021 Started Feb 2019

Fundación Española de Reumatología

Modifications of titanium surface with a nanometric structure and sintered with calcium ions.

PI: Rodolfo Gómez Bahamonde
Financing agency: Private company Medcom Tech SA .
Financing (in thousands of euros): 4.000€
Duration funding period: 2018